Work

Relationship of sipuleucel-T with time to first use of opioid analgesics (TFOA) in patients (pts) with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC) on the IMPACT trial.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.74

Authors: Eric Jay Small, Celestia S. Higano, Philip W. Kantoff, James Boyd Whitmore, Mark Walter Frohlich, Daniel Peter Petrylak

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of Washington, Dana-Farber Cancer Institute, Dendreon (United States), Yale University, Smilow Cancer Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589708787

Cites:

Cited by: 2

Related to: 10